相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An atlas of substrate specificities for the human serine/threonine kinome
Jared L. Johnson et al.
NATURE (2023)
A PDK-1 allosteric agonist improves spatial learning and memory in a ?APP/PS-1 transgenic mouse-high fat diet intervention model of Alzheimer?s disease
Henry Querfurth et al.
BEHAVIOURAL BRAIN RESEARCH (2023)
RSK inhibitors as potential anticancer agents: Discovery, optimization, and challenges
Ying Sun et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
Modulation of the substrate specificity of the kinase PDK1 by distinct conformations of the full- length protein
Mariana Sacerdoti et al.
SCIENCE SIGNALING (2023)
PDK1:PKCa heterodimer association-dissociation dynamics in single-molecule diffusion tracks on a target membrane
Moshe T. Gordon et al.
BIOPHYSICAL JOURNAL (2023)
Axelrod Symposium Protein Kinases in Tune- Special Section-Minireview
Timothy R. Baffi et al.
MOLECULAR PHARMACOLOGY (2022)
S6K1-mediated phosphorylation of PDK1 impairs AKT kinase activity and oncogenic functions
Qiwei Jiang et al.
NATURE COMMUNICATIONS (2022)
Activation of the essential kinase PDK1 by phosphoinositide-driven trans-autophosphorylation
Aleksandra Levina et al.
NATURE COMMUNICATIONS (2022)
Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer's Disease
Shaobin Yang et al.
CELLS (2022)
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma
Weijia Cai et al.
CANCER RESEARCH (2022)
Genetic inhibition of PDK1 robustly reduces plaque deposition and ameliorates gliosis in the 5xFAD mouse model of Alzheimer's disease
Xiaolian Ye et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2022)
Single-molecule studies reveal regulatory interactions between master kinases PDK1, AKT1, and PKC
Moshe T. Gordon et al.
BIOPHYSICAL JOURNAL (2021)
SGK1 in Human Cancer: Emerging Roles and Mechanisms
Yiwen Sang et al.
FRONTIERS IN ONCOLOGY (2021)
Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery
Jigang Fan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Doxycycline Changes the Transcriptome Profile of mIMCD3 Renal Epithelial Cells
Hyun Jun Jung et al.
FRONTIERS IN PHYSIOLOGY (2021)
The role of the p90 ribosomal S6 kinase family in prostate cancer progression and therapy resistance
Ryan Cronin et al.
ONCOGENE (2021)
mTORC2 controls the activity of PKC and Akt by phosphorylating a conserved TOR interaction motif
Timothy R. Baffi et al.
SCIENCE SIGNALING (2021)
Structure of autoinhibited Akt1 reveals mechanism of PIP3-mediated activation
Linda Truebestein et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Akt Pathway Inhibitors
Nne E. Uko et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Renaissance of Allostery to Disrupt Protein Kinase Interactions
Alejandro E. Leroux et al.
TRENDS IN BIOCHEMICAL SCIENCES (2020)
The Impact of the PI3K/Akt Signaling Pathway in Anxiety and Working Memory in Young and Middle-Aged PDK1 K465E Knock-In Mice
Lydia Gimenez-Llort et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2020)
Synergistic Allostery in Multiligand-Protein Interactions
Abhijeet Ghode et al.
BIOPHYSICAL JOURNAL (2020)
A patent update on PDK1 inhibitors (2015-present)
Simona Sestito et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2019)
Prospects for pharmacological targeting of pseudokinases
Jennifer E. Kung et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Production of seedable Amyloid-β peptides in model of prion diseases upon PrPSc-induced PDK1 overactivation
Juliette Ezpeleta et al.
NATURE COMMUNICATIONS (2019)
A Complex Interplay of Anionic Phospholipid Binding Regulates 3′-Phosphoinositide-Dependent-Kinase-1 Homodimer Activation
Gloria de las Heras-Martinez et al.
SCIENTIFIC REPORTS (2019)
The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1
Xinyuan Xu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2019)
The multifaceted allosteric regulation of Aurora kinase A
Nicholas Mark Levinson
BIOCHEMICAL JOURNAL (2018)
Protein kinase C: perfectly balanced
Alexandra C. Newton
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Conformational sampling of membranes by Akt controls its activation and inactivation
Iva Lucic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors
Emilie Clement et al.
SCIENCE SIGNALING (2018)
AGC kinases, mechanisms of regulation and innovative drug development
Alejandro E. Leroux et al.
SEMINARS IN CANCER BIOLOGY (2018)
Skp2-dependent reactivation of AKT drives resistance to PI3K inhibitors
Emilie Clement et al.
SCIENCE SIGNALING (2018)
Identification of a multifunctional docking site on the catalytic unit of phosphodiesterase-4 (PDE4) that is utilised by multiple interaction partners
Kirsty F. Houslay et al.
BIOCHEMICAL JOURNAL (2017)
Switching Aurora-A kinase on and off at an allosteric site
Richard Bayliss et al.
FEBS JOURNAL (2017)
Insulin action and resistance in obesity and type 2 diabetes
Michael P. Czech
NATURE MEDICINE (2017)
PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242
Chunmei Yang et al.
ONCOTARGET (2017)
SGK1 Is a Critical Component of an AKT-Independent Pathway Essential for PI3K-Mediated Tumor Development and Maintenance
Arturo Orlacchio et al.
CANCER RESEARCH (2017)
AKT/PKB Signaling: Navigating the Network
Brendan D. Manning et al.
CELL (2017)
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms
Jose M. Arencibia et al.
ACS CHEMICAL BIOLOGY (2017)
Lipid regulators of Pkh2 in Candida albicans, the protein kinase ortholog of mammalian PDK1
Daniel Pastor-Flores et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2016)
The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumourgrowth
Ruzica Bago et al.
EMBO JOURNAL (2016)
Mutation of the 3-Phosphoinositide-Dependent Protein Kinase 1 (PDK1) Substrate-Docking Site in the Developing Brain Causes Microcephaly with Abnormal Brain Morphogenesis Independently of Akt, Leading to Impaired Cognition and Disruptive Behaviors
Lluis Cordon-Barris et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase
Joerg O. Schulze et al.
CELL CHEMICAL BIOLOGY (2016)
Discovery of a Potent Allosteric Kinase Modulator by Combining Computational and Synthetic Methods
Edwin Kroon et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Integration of signaling in the kinome: Architecture and regulation of the αC Helix
Susan S. Taylor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2015)
PDK1 disruptors and modulators: a patent review
Muhammad Jahangir Hossen et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based Docking
T. Justin Rettenmaier et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Molecular Basis of the Activity and the Regulation of the Eukaryotic-like S/T Protein Kinase PknG from Mycobacterium tuberculosis
Maria-Natalia Lisa et al.
STRUCTURE (2015)
Dynamics-Driven Allostery in Protein Kinases
Alexandr P. Kornev et al.
TRENDS IN BIOCHEMICAL SCIENCES (2015)
Fine-tuning the intensity of the PKB/Akt signal enables diverse physiological responses
Xiangyu Zhou et al.
CELL CYCLE (2014)
Molecular Mechanism of Regulation of the Atypical Protein Kinase C by N-terminal Domains and an Allosteric Small Compound
Hua Zhang et al.
CHEMISTRY & BIOLOGY (2014)
A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1
T. Justin Rettenmaier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6
Jennifer L. Stamos et al.
ELIFE (2014)
PIF-Pocket as a Target for C. albicans Pkh Selective Inhibitors
Daniel Pastor-Flores et al.
ACS CHEMICAL BIOLOGY (2013)
The PH Domain of Phosphoinositide-Dependent Kinase-1 Exhibits a Novel, Phospho-Regulated Monomer-Dimer Equilibrium with Important Implications for Kinase Domain Activation: Single-Molecule and Ensemble Studies
Brian P. Ziemba et al.
BIOCHEMISTRY (2013)
PKA: Lessons learned after twenty years
Susan S. Taylor et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
AGC protein kinases: From structural mechanism of regulation to allosteric drug development for the treatment of human diseases
Jose M. Arencibia et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
αC helix displacement as a general approach for allosteric modulation of protein kinases
Lorenzo Palmieri et al.
DRUG DISCOVERY TODAY (2013)
Transition from Heterotypic to Homotypic PDK1 Homodimerization Is Essential for TCR-Mediated NF-κB Activation
Jung-Ah Kang et al.
JOURNAL OF IMMUNOLOGY (2013)
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Jonathan M. Ostrem et al.
NATURE (2013)
PDK1 decreases TACE-mediated α-secretase activity and promotes disease progression in prion and Alzheimer's diseases
Mathea Pietri et al.
NATURE MEDICINE (2013)
The activation loop of PKA catalytic isoforms is differentially phosphorylated by Pkh protein kinases in Saccharomyces cerevisiae
Steven Haesendonckx et al.
BIOCHEMICAL JOURNAL (2012)
Substrate-Selective Inhibition of Protein Kinase PDK1 by Small Compounds that Bind to the PIF-Pocket Allosteric Docking Site
Katrien Busschots et al.
CHEMISTRY & BIOLOGY (2012)
Regulation of Protein Kinase C-related Protein Kinase 2 (PRK2) by an Intermolecular PRK2-PRK2 Interaction Mediated by Its N-terminal Domain
Angelika F. Bauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
2-(3-Oxo-1,3-diphenylpropyl)malonic Acids as Potent Allosteric Ligands of the PIF Pocket of Phosphoinositide-Dependent Kinase-1: Development and Prodrug Concept
Adriana Wilhehm et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists
David Koes et al.
PLOS ONE (2012)
PDK1 inhibitors
Elisa Barile et al.
PHARMACEUTICAL PATENT ANALYST (2012)
Perspectives in PDK1 evolution Insights from photosynthetic and non-photosynthetic organisms
Anna C. Nelson Dittrich et al.
PLANT SIGNALING & BEHAVIOR (2012)
Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1
Ayaz Najafov et al.
BIOCHEMICAL JOURNAL (2011)
Discovery of a potent and highly selective PDK1 inhibitor via fragment-based drug discovery
Daniel A. Erlanson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
PDK1 Attenuation Fails to Prevent Tumor Formation in PTEN-Deficient Transgenic Mouse Models
Katharine Ellwood-Yen et al.
CANCER RESEARCH (2011)
Allosteric Regulation of Protein Kinase PKCζ by the N-Terminal C1 Domain and Small Compounds to the PIF-Pocket
Laura A. Lopez-Garcia et al.
CHEMISTRY & BIOLOGY (2011)
Genetic and Pharmacological Inhibition of PDK1 in Cancer Cells CHARACTERIZATION OF A SELECTIVE ALLOSTERIC KINASE INHIBITOR
Kumiko Nagashima et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Hydrophobic Motif Phosphorylation Is Not Required for Activation Loop Phosphorylation of p70 Ribosomal Protein S6 Kinase 1 (S6K1)
Malik M. Keshwani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Chronically Increased S6K1 Is Associated with Impaired IRS1 Signaling in Skeletal Muscle of GDM Women with Impaired Glucose Tolerance Postpartum
Linda A. Barbour et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
4-Benzimidazolyl-3-Phenylbutanoic Acids As Novel Pif-Pocket-Targeting Allosteric Inhibitors of Protein Kinase PKCζ
Wolfgang Froehner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Catalytic Control in the EGF Receptor and Its Connection to General Kinase Regulatory Mechanisms
Natalia Jura et al.
MOLECULAR CELL (2011)
Turning a protein kinase on or off from a single allosteric site via disulfide trapping
Jack D. Sadowsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The minimal kinome of Giardia lamblia illuminates early kinase evolution and unique parasite biology
Gerard Manning et al.
GENOME BIOLOGY (2011)
Comparative analysis of fungal protein kinases and associated domains
Idit Kosti et al.
BMC GENOMICS (2010)
Discovery of PDK1 Kinase Inhibitors with a Novel Mechanism of Action by Ultrahigh Throughput Screening
Ekaterina V. Bobkova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Molecular Pharmacology and Antitumor Activity of PHT-427, a Novel Akt/Phosphatidylinositide-Dependent Protein Kinase 1 Pleckstrin Homology Domain Inhibitor
Emmanuelle J. Meuillet et al.
MOLECULAR CANCER THERAPEUTICS (2010)
The nuts and bolts of AGC protein kinases
Laura R. Pearce et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Crystal Structure of Human AKT1 with an Allosteric Inhibitor Reveals a New Mode of Kinase Inhibition
Wen-I Wu et al.
PLOS ONE (2010)
Regulation of 3-Phosphoinositide-Dependent Protein Kinase 1 Activity by Homodimerization in Live Cells
Thomas A. Masters et al.
SCIENCE SIGNALING (2010)
Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization
Elizabeth Iorns et al.
BIOCHEMICAL JOURNAL (2009)
AKT-Independent Signaling Downstream of Oncogenic PIK3CA Mutations in Human Cancer
Krishna M. Vasudevan et al.
CANCER CELL (2009)
Identification of Allosteric PIF-Pocket Ligands for PDK1 using NMR-Based Fragment Screening and 1H-15N TROSY Experiments
Brian J. Stockman et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
Regulation of the Interaction between Protein Kinase C-related Protein Kinase 2 (PRK2) and Its Upstream Kinase, 3-Phosphoinositide-dependent Protein Kinase 1 (PDK1)
Rosalia Dettori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Contribution of Non-catalytic Core Residues to Activity and Regulation in Protein Kinase A
Jie Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
3,5-Diphenylpent-2-enoic Acids as Allosteric Activators of the Protein Kinase PDK1: Structure-Activity Relationships and Thermodynamic Characterization of Binding as Paradigms for PIF-Binding Pocket-Targeting Compounds
Adriana Stroba et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
RSK Is a Principal Effector of the RAS-ERK Pathway for Eliciting a Coordinate Promotile/Invasive Gene Program and Phenotype in Epithelial Cells
Ulrik Doehn et al.
MOLECULAR CELL (2009)
Structure and allosteric effects of low-molecular-weight activators on the protein kinase PDK1
Valerie Hindie et al.
NATURE CHEMICAL BIOLOGY (2009)
A chimeric mechanism for polyvalent trans-phosphorylation of PKA by PDK1
Robert A. Romano et al.
PROTEIN SCIENCE (2009)
AGCVIII kinases: at the crossroads of cellular signaling
Yan Zhang et al.
TRENDS IN PLANT SCIENCE (2009)
TOR regulation of AGC kinases in yeast and mammals
Estela Jacinto et al.
BIOCHEMICAL JOURNAL (2008)
New anti-cancer role for PDK1 inhibitors: preventing resistance to tamoxifen
Christian Peifer et al.
BIOCHEMICAL JOURNAL (2008)
Small-Molecule Inhibitors of PDK1
Christian Peifer et al.
CHEMMEDCHEM (2008)
The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
Valeria Facchinetti et al.
EMBO JOURNAL (2008)
The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation
Sonja Baumli et al.
EMBO JOURNAL (2008)
S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-α Signaling through IKK2
Jin Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance
Jose R. Bayascas et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance
Frederic Tremblay et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Mechanism for activation of the growth factor-activated AGC kinases by turn motif phosphorylation
Camilla Hauge et al.
EMBO JOURNAL (2007)
Allosteric activation of the protein kinase PDK1 with low molecular weight compounds
Matthias Engel et al.
EMBO JOURNAL (2006)
Role of the PH domain in regulating in vitro autophosphorylation events required for reconstitution of PDK1 catalytic activity
Xinxin Gao et al.
BIOORGANIC CHEMISTRY (2006)
The Dictyostelium kinome -: Analysis of the protein kinases from a simple model organism
Jonathan M. Goldberg et al.
PLOS GENETICS (2006)
Hypomorphic mutation of PDK1 suppresses tumorigenesis in PTEN+/- mice
JR Bayascas et al.
CURRENT BIOLOGY (2005)
Regulation of protein kinases: Controlling activity through activation segment conformation
B Nolen et al.
MOLECULAR CELL (2004)
Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity
SH Um et al.
NATURE (2004)
Phosphoinositide-dependent kinase-1 orthologues from five eukaryotes are activated by the hydrophobic motif in AGC kinases
J Silber et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-pliosphoinositide-dependent protein kinase-1 inhibitors (Publication with Expression of Concern. See vol. 79, pg. 1716, 2019)
JX Zhu et al.
CANCER RESEARCH (2004)
Mouse 3-phosphoinositide-dependent protein kinase-1 undergoes dimerization and trans-phosphorylation in the activation loop
MJ Wick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation
BJ Collins et al.
EMBO JOURNAL (2003)
A novel mechanism for activation of the protein kinase aurora A
PA Eyers et al.
CURRENT BIOLOGY (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP
J Yang et al.
NATURE STRUCTURAL BIOLOGY (2002)
A phosphoserine/threonine-binding pocket in AGC kinases and PDK1 mediates activation by hydrophobic motif phosphorylation
M Frödin et al.
EMBO JOURNAL (2002)
The turn motif is a phosphorylation switch that regulates the binding of Hsp70 to protein kinase C
TY Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
High resolution crystal structure of the human PDK1 catalytic domain defines the regulatory phosphopeptide docking site
RM Biondi et al.
EMBO JOURNAL (2002)
The conformational plasticity of protein kinases
M Huse et al.
CELL (2002)
The phosphoinositide-dependent kinase, PDK-1, phosphorylates conventional protein kinase C isozymes by a mechanism that is independent of phosphoinositide 3-kinase
ED Sonnenburg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB
RM Biondi et al.
EMBO JOURNAL (2001)
Dynamics of cAMP-dependent protein kinase
DA Johnson et al.
CHEMICAL REVIEWS (2001)
The carboxyl terminus of protein kinase C provides a switch to regulate its interaction with the phosphoinositide-dependent kinase, PDK-1
TY Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1)
CC King et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A 3-phosphoinositide-dependent protein kinase-1 (PDK1) docking site is required for the phosphorylation of protein kinase Cζ (PKCζ) and PKC-related kinase 2 by PDK1
A Balendran et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A phosphoserine-regulated docking site in the protein kinase RSK2 that recruits and activates PDK1
M Frödin et al.
EMBO JOURNAL (2000)
Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA
RM Biondi et al.
EMBO JOURNAL (2000)
分享论文
